title: Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
authors.affiliation: Istituto di Chirurgia Sperimentale e dei Trapianti, IRCCS Ospedale Maggiore, Milano, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Rossi
authors.forename: P
authors.initials: P
authors.lastname: Reggiani
authors.forename: R
authors.initials: R
authors.lastname: Orsenigo
authors.forename: L
authors.initials: L
authors.lastname: Leoni
authors.forename: L
authors.initials: L
authors.lastname: Caccamo
authors.forename: M
authors.initials: M
authors.lastname: Doglia
authors.forename: S
authors.initials: S
authors.lastname: Gatti
authors.forename: U
authors.initials: U
authors.lastname: Maggi
authors.forename: G
authors.initials: G
authors.lastname: Paone
authors.forename: D
authors.initials: D
authors.lastname: Galmarini
authors.forename: L R
authors.initials: LR
authors.lastname: Fassati
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D012189:Retrospective Studies; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone